Cude KJ - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway.

Bauer KS, Cude KJ, Dixon SC, Kruger EA, Figg WD. Bauer KS, et al. Among authors: cude kj. J Pharmacol Exp Ther. 2000 Jan;292(1):31-7. J Pharmacol Exp Ther. 2000. PMID: 10604929

The androgen receptor: genetic considerations in the development and treatment of prostate cancer.

Cude KJ, Dixon SC, Guo Y, Lisella J, Figg WD. Cude KJ, et al. J Mol Med (Berl). 1999 May;77(5):419-26. doi: 10.1007/s001090050372. J Mol Med (Berl). 1999. PMID: 10426191 Review.

The role of an androgen receptor polymorphism in the clinical outcome of patients with metastatic prostate cancer.

Cude KJ, Montgomery JS, Price DK, Dixon SC, Kincaid RL, Kovacs KF, Venzon DJ, Liewehr DJ, Johnson ME, Reed E, Figg WD. Cude KJ, et al. Urol Int. 2002;68(1):16-23. doi: 10.1159/000048412. Urol Int. 2002. PMID: 11803263

Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.

Bennett CL, Price DK, Kim S, Liu D, Jovanovic BD, Nathan D, Johnson ME, Montgomery JS, Cude K, Brockbank JC, Sartor O, Figg WD. Bennett CL, et al. J Clin Oncol. 2002 Sep 1;20(17):3599-604. doi: 10.1200/JCO.2002.11.085. J Clin Oncol. 2002. PMID: 12202660

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters